Clinical trial
Celecoxib Pain Management Following Superficial Parotidectomy: Opioid Sparing Protocol
NCT06505187 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Celecoxib Pain Management Following Superficial Parotidectomy: Opioid Sparing Protocol
- Lead sponsor
- University of Wisconsin, Madison
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- February 28, 2025
- Completion date
- September 30, 2027
- Enrollment
- 84 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
parotidectomy